Please provide your email address to receive an email when new articles are posted on . A dual-chamber leadless pacemaker met 3-month safety and efficacy performance goals. The device avoids ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window NEW ORLEANS -- A ...

Patients receiving leadless pacemakers experience overall fewer short-term and mid-term complications than those receiving traditional transvenous pacemakers, a new study found. Patients receiving ...

A leadless cardiac pacemaker showed "good safety and reliable function" during the initial six months of follow-up in the LEADLESS II study, investigators reported. A leadless cardiac pacemaker showed ...

A 67-year-old man with acute anterolateral myocardial infarction had recurrent ventricular fibrillation that required insertion of temporary pacemaker. When a permanent pacemaker was inserted stable ...

Pacing threshold varies during the 24 hours in children (Fig. 2). This variability is low, not exceeding 0.2 V (0.03 ± 0.01 V), so it is unlikely to affect pacemaker programming. There were no ...

ORLANDO, FL—The second major trial this year shows good safety and efficacy for a leadless intracardiac transcatheter pacing system in the short term, but some in the electrophysiology community worry ...

Please provide your email address to receive an email when new articles are posted on . Transcatheter tricuspid valve replacement in patients with trans-tricuspid valve pacemaker leads without ...

Leadless pacemaker technology represents a significant advancement in cardiac rhythm management, eliminating the need for transvenous leads and reducing many of the complications associated with ...

BOSTON -- A leadless pacemaker reliably communicated with a subcutaneous implantable cardioverter-defibrillator (S-ICD) to deliver anti-tachycardia (ATP) and bradycardia pacing, the MODULAR ATP study ...

This was a prospective, nonrandomized study involving patients who underwent implantation of a Medtronic Kappa 901 pacemaker from June 2002 to October 2003 at our institution, either as a first/new ...